Dr. Muhammad Omer O. Jamil, MD

Dr. Jamil practices at Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network.

Dr. Jamil's NPI, 1245545508, was assigned on August 11, 2010. Dr. Jamil holds West Virginia license 26946.

Dr. Jamil's primary practice is Cabell Huntington Hospital, at 1340 Hal Greer Boulevard, Huntington, WV 25701 in Cabell County. The practice phone is (304) 526-2000.

Dr. Jamil's primary practice is Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network. Dr. Jamil is also affiliated with St. Mary's Medical Center. The medical group on file is Cabell Huntington Hospital Anesthesia. Dmand AI also links Dr. Jamil to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamil practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jamil's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jamil is licensed in West Virginia.

CMS data shows 2,583 Medicare services from Dr. Jamil across 11 procedure codes in 2024, for 521 Medicare patients. Medicare paid $198,364 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 521 Medicare patients who saw Dr. Jamil in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jamil's median patient age at 69, with 56% women.

In 2024, Dr. Jamil wrote 2,133 Medicare Part D claims for 342 patients. 66% of them were for generic drugs. CMS names the drug for 1,861 of them, across 50 drugs with 11 or more claims each, at $7,505,373 in total drug cost. In 2023, CMS named 1,582 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 40 out of 100 for Dr. Jamil for performance year 2024, reported individually. Dr. Jamil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jamil as offering telehealth.

CMS Open Payments shows 59 general payments to Dr. Jamil from 19 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 63% of the total. Millennium Pharmaceuticals, Inc. paid the most, $1,205.